【24h】

Activation of MAP kinase by the A_2A-Adenosine receptor

机译:A_2A-腺苷受体的MAP激酶激活

获取原文

摘要

The A2A-adenosine receptor, a prototypical Gs-coupled receptor, activates MAP kinase in a manner independent of cAMP in primary human endothelial cells. In order to delineate signalling pathways that link the receptor to the regulation of MAP kinase, the human A_2A-receptor was heterologously expressed in CHO and HEK293 cells. In both cell lines, A_2A-agonist mediated cAMP accumulation was accompanied by activation of the small G protein rap1; however, rap1 mediates A_2A-receptor-dependent MAP kinase activation only in CHO cells (the signalling cascade being composed of G_s, adenylyl cyclase, protein kinase A, rapl and B-raf). The S17N-mutant of rapl was not dominant negative; (i) following transient expression, rapl(S17N) failed to inhibit receptor-dependent MAP kinase activation, (ii) After receptor-activation, rapl(S17N) was recovered in the active form with a GST(glutathionS-transferase)-fusion protein comprising the rapl-binding domain of ralGDS. (iii) In CHO cells, A_2A-agonists promoted the association of rapl(S17N) with B-raf. In HEK293 cells, activation of MAP kinase by A_2A-agonists required p21~(ras), because it was blocked after expression of the dominant negative version ras(S17N); in addition, an increase active p21~(ras) (detected by pull-downs with a GST-fusion protein encompassing the ras-binding domain of raf-1) was seen after A2A-receptor stimulation. We conclude that the A_2A-receptor has the capacity to activate MAP kinase via at least two signalling pathways.
机译:所述A 2A - 腺苷受体,原型G s - 偶联受体,激活MAP在独立方式中cAMP的原代人内皮细胞激酶。为了描绘该受体链接到的MAP激酶的调节信号转导途径,所述人A_2A受体在CHO和HEK293细胞中异源表达。在两种细胞系中,A_2A激动剂介导的cAMP的积累是伴随着小G蛋白RAP1的激活;然而,RAP1介导A_2A受体依赖性MAP激酶的激活只在CHO细胞中(信令级联部分由G_S,腺苷酸环化酶的,蛋白激酶A,rapL遗传和B-RAF)。该S17N突变rapL遗传的不是显性负; (ⅰ)下面的瞬时表达,rapL遗传(S17N)不能抑制受体依赖性MAP激酶的活化,(ⅱ)受体活化后,rapL遗传(S17N)回收与GST(glutathionS转移) - 融合蛋白的活性形式包括RALGDS的rapL遗传结合结构域。 (ⅲ)在CHO细胞中,A_2A激动剂促进rapL遗传的(S17N)与B-RAF的关联。在HEK293细胞中,MAP的活化激酶通过A_2A激动剂所需的p21〜(RAS),因为它是显性负版本RAS(S17N)的表达之后阻止;此外,增加了活性的p21〜(RAS)(由上拉起伏与GST融合蛋白包含RAF-1的ras基因结合结构域检测的)A2A受体刺激后观察。我们的结论是A_2A受体具有激活MAP激酶通过至少两个信号通路的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号